SCHEMBL7542072

SCHEMBL7542072

Cc1cc(COc2ccc(C(=O)N[C@H]3CN(C(=O)O)CC3C(=O)NO)cc2)c2ccccc2n1

nearest known ligand 0.89

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 5/20 0.89
MMP9 P14780 2/20 0.83
MMP3 P08254 1/20 0.77
MMP7 P09237 1/20 0.77
MMP10 P09238 1/20 0.77
MMP8 P22894 1/20 0.77
MMP12 P39900 1/20 0.77
MMP13 P45452 1/20 0.77
MMP14 P50281 1/20 0.77
ADAM17 P78536 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7542064 1.00 MMP2 (0.89) MMP2MMP9MMP3MMP7MMP10
SCHEMBL5898183 1.00 MMP2 (0.89) MMP2MMP9MMP3MMP7MMP10
SCHEMBL5897938 1.00 MMP2 (0.89) MMP2MMP9MMP3MMP7MMP10
SCHEMBL5898139 1.00 MMP2 (0.89) MMP2MMP9MMP3MMP7MMP10
SCHEMBL5897854 1.00 MMP2 (0.89) MMP2MMP9MMP3MMP7MMP10
SCHEMBL7542099 1.00 MMP2 (0.89) MMP2MMP9MMP3MMP7MMP10
Trifluoroacetic Acid SCHEMBL5898274 0.95 MMP2 (0.81) MMP2MMP9MMP3MMP7MMP10
SCHEMBL5898234 0.94 MMP2 (1.00) MMP2MMP9MMP3MMP7MMP10
SCHEMBL7435467 0.94 MMP2 (1.00) MMP2MMP9MMP3MMP7MMP10
SCHEMBL5898237 0.93 MMP2 (0.85) MMP2MMP9MMP3MMP7MMP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263755-A2 CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA Bristol-Myers Squibb Pharma Company (US) 2002-12-11 EP disclosed
WO-2001070673-A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-27 WO disclosed